Literature DB >> 15817608

The p53 story: layers of complexity.

Antony W Braithwaite1, Janice A Royds, Paul Jackson.   

Abstract

This report is a summary of the presentations at the 12th International p53 Workshop, held in November 2004, Dunedin, New Zealand. The Convenor of the organizing committee was Antony Braithwaite, University of Otago, Dunedin. Janice Royds and Paul Jackson were also members of the organizing committee. There were 61 oral presentations and 101 posters.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15817608     DOI： 10.1093/carcin/bgi091

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN： 0143-3334            Impact factor:   4.944


  17 in total

1.  Antitumor cytotoxicity induced by bone-marrow-derived antigen-presenting cells is facilitated by the tumor suppressor protein p53 via regulation of IL-12.

Authors:  Tania L Slatter; Michelle Wilson; Chingwen Tang; Hamish G Campbell; Vernon K Ward; Vivienne L Young; David Van Ly; Nicholas I Fleming; Antony W Braithwaite; Margaret A Baird
Journal:  Oncoimmunology       Date:  2015-12-17       Impact factor: 8.110

Review 2.  Transcriptional modulation induced by ionizing radiation: p53 remains a central player.

Authors:  Sharon Rashi-Elkeles; Ran Elkon; Seagull Shavit; Yaniv Lerenthal; Chaim Linhart; Ana Kupershtein; Ninette Amariglio; Gideon Rechavi; Ron Shamir; Yosef Shiloh
Journal:  Mol Oncol       Date:  2011-07-07       Impact factor: 6.603

Review 3.  Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancer.

Authors:  Aravind Suppiah; John Greenman
Journal:  World J Gastroenterol       Date:  2013-08-07       Impact factor: 5.742

4.  Anticancer potential of an ethanol extract of Asiasari radix against HCT-116 human colon cancer cells in vitro.

Authors:  Se-Mi Oh; Jinhee Kim; Jun Lee; Jin-Mu Yi; Dal-Seok Oh; Ok-Sun Bang; No Soo Kim
Journal:  Oncol Lett       Date:  2012-11-01       Impact factor: 2.967

5.  The molecular genetics of breast cancer and targeted therapy.

Authors:  Rachel Suter; James A Marcum
Journal:  Biologics       Date:  2007-09

6.  Molecular epidemiology of gastric cancer: current status and future prospects.

Authors:  Zhibin Hu; Jaffer A Ajani; Qingyi Wei
Journal:  Gastrointest Cancer Res       Date:  2007-01

7.  P53 immunohistochemical expression does not correlate with clinical features in 207 carcinomas of the oral cavity and in the head and neck region.

Authors:  Alexander Gröbe; Henning Hanken; Ahmed Al-Dam; Georg Cachovan; Ralf Smeets; Antje Krohn; Till Clauditz; Tobias Grob; Ronald Simon; Guido Sauter; Lan Kluwe; Max Heiland; Marco Blessmann
Journal:  Clin Oral Investig       Date:  2013-02-13       Impact factor: 3.573

8.  Establishment of transplantable porcine tumor cell lines derived from MHC-inbred miniature swine.

Authors:  Patricia S Cho; Diana P Lo; Krzysztof J Wikiel; Haley C Rowland; Rebecca C Coburn; Isabel M McMorrow; Jennifer G Goodrich; J Scott Arn; Robert A Billiter; Stuart L Houser; Akira Shimizu; Yong-Guang Yang; David H Sachs; Christene A Huang
Journal:  Blood       Date:  2007-08-16       Impact factor: 22.113

9.  Arsenite induced poly(ADP-ribosyl)ation of tumor suppressor P53 in human skin keratinocytes as a possible mechanism for carcinogenesis associated with arsenic exposure.

Authors:  Elena V Komissarova; Toby G Rossman
Journal:  Toxicol Appl Pharmacol       Date:  2009-12-28       Impact factor: 4.219

10.  Mutations in p53, p53 protein overexpression and breast cancer survival.

Authors:  Pavel Rossner; Marilie D Gammon; Yu-Jing Zhang; Mary Beth Terry; Hanina Hibshoosh; Lorenzo Memeo; Mahesh Mansukhani; Chang-Min Long; Gail Garbowski; Meenakshi Agrawal; Tara S Kalra; Mia M Gaudet; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella
Journal:  J Cell Mol Med       Date:  2008-10-16       Impact factor: 5.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.